Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2664PDF: 1079HTML: 119 -
-
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2203PDF: 1490HTML: 267 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2325PDF: 987HTML: 7624Untitled: 276Fig2: 184Fig3: 169Fig4: 180 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1714PDF: 626HTML: 1515Figure 1: MRI demonstrating Aspergillus synovitis: 184Figure 2:MRI demonstrating Aspergillus synovitis: 189 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2272PDF: 934HTML: 302 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3553PDF: 2413HTML: 1465 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3197PDF: 1580HTML: 259 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2094PDF: 607Suppl. Files: 283HTML: 169 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3248PDF: 1612HTML: 430 -
-
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2609PDF: 1611HTML: 2354Table1: 190 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1809PDF: 809HTML: 10235Figures 1,2,3: 175 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3140PDF: 1828HTML: 3603 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7967PDF: 4138HTML: 7369 -
How I treat acute and persistent sickle cell pain
1928PDF: 1117HTML: 485 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2019PDF: 800HTML: 1036 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1844PDF: 835HTML: 1581 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1110PDF: 486HTML: 8165 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1545PDF: 588HTML: 216 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
874PDF: 624HTML: 108 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2936PDF: 982HTML: 2063Cover letter: 179 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4319PDF: 1765HTML: 1107 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2916PDF: 691HTML: 1934figure 1: 169figure 2: 176 -
DIAGNOSTIC VALUE OF SIMULTANEOUS MEASUREMENT OF PROCALCITONIN, INTERLEUKIN-6 AND HS CRP IN PREDICTION OF EARLY-ONSET NEONATAL SEPSIS
2027PDF: 1205HTML: 1934Untitled: 148TaBles Neinates sepsis: 173 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1324PDF: 971HTML: 297Suppl. Figure: 182Suppl. Tables: 205 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3679PDF: 1284HTML: 729Figure 2: 452Figure 1: 3117 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2411PDF: 1591HTML: 627







